Molecular CellMolecular BiologyPeer-reviewed journal article
Impeding transcription of expanded microsatellite repeats by deactivated Cas9
Belinda S. Pinto, Tanvi Saxena, Ruan OliveiraiD, Héctor R. Méndez‐Gómez, John D. ClearyiD, Lance T. DenesiD, Ona L. McConnell, Juan D. ArboledaiD, Guangbin XiaiD, Maurice S. SwansoniD, Eric T. WangiD
Abstract
Transcription of expanded microsatellite repeats is associated with multiple human diseases, including myotonic dystrophy, Fuchs endothelial corneal dystrophy, and C9orf72-ALS/FTD. Eliminating or reducing production of RNA and proteins arising from these expanded loci holds therapeutic benefit. Here, we tested the hypothesis that a deactivated form of the Cas9 enzyme impedes transcription across expanded microsatellites. We observed a repeat length-, PAM-, and strand-dependent reduction in the abundance of repeat-containing RNAs upon targeting dCas9 directly to repeat sequences. Aberrant splicing patterns were rescued in DM1 cells, and production of RAN peptides characteristic of DM1, DM2, and C9orf72-ALS/FTD cells was drastically decreased. Systemic delivery of dCas9/gRNA by adeno-associated virus led to reductions in pathological RNA foci, rescue of chloride channel 1 protein expression, and decreased myotonia. These observations suggest that transcription of microsatellite repeat-containing RNAs is more sensitive to perturbation than transcription of other RNAs, indicating potentially viable strategies for therapeutic intervention.
- Citations
- 130
- FWCI
- 7.03
- Field percentile
- top 2%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- TALEN-induced contraction of CTG trinucleotide repeats in myotonic dystrophy type 1 cells
Laureline Bétemps, Stéphane Descorps-Declère, … Guy‐Franck Richard·bioRxiv·Oct 14, 2023
- Resection and repair of a Cas9 double-strand break at CTG trinucleotide repeats induces local and extensive chromosomal rearrangements
Valentine Mosbach, David Viterbo, … Guy‐Franck Richard·PLoS GeneticsPeer-reviewed·Jul 16, 2020
- Targeting Toxic Nuclear RNA Foci with CRISPR-Cas13 to Treat Myotonic Dystrophy
Pornthida Poosala, Sean R. Lindley, … Douglas M. Anderson·bioRxiv·Jul 26, 2019
- Differential efficacies of Cas nucleases on microsatellites involved in human disorders and associated off-target mutations
Lucie Poggi, Lisa Emmenegger, … Guy‐Franck Richard·Nucleic Acids ResearchPeer-reviewed·Jul 6, 2021
- Reversal of molecular pathology by RNA-targeting Cas9 in a myotonic dystrophy mouse model
Ranjan Batra, David A. Nelles, … Gene Wei-Ming Yeo·bioRxiv·Sep 4, 2017
- Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo
Liam Kempthorne, Deniz Vaizoglu, … Adrian M. Isaacs·Nature CommunicationsPeer-reviewed·Jan 8, 2025